Increased prevalence of inhibitors in Hispanic patients with severe haemophilia A enrolled in the Universal Data Collection database.
about
FVIII inhibitors: pathogenesis and avoidancePrevalent inhibitors in haemophilia B subjects enrolled in the Universal Data Collection database.The Epidemiology of FVIII Inhibitors in Indian Haemophilia A PatientsGame, set, match for factor VIII mismatch?Men with severe hemophilia in the United States: birth cohort analysis of a large national databaseThe prevalence of factor VIII and IX inhibitors among Saudi patients with hemophilia: Results from the Saudi national hemophilia screening program.Factor VIII inhibitors in hemophilia A: rationale and latest evidenceJoint WFH-ISTH session: issues in clinical trial design.Inhibitors in haemophilia: what have we learned from registries? A systematic review.Novel therapeutic approaches for haemophilia.Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator.The role of previously untreated patient studies in understanding the development of FVIII inhibitors.The Development of FVIII Inhibitors in Relation to IL10 Gene Polymorphism in Hemophilia A Egyptian Pediatric Patients.Recommendations for authors of manuscripts reporting inhibitor cases developed in previously treated patients with hemophilia: communication from the SSC of the ISTH.Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres.Comparison of ultrasound and magnetic resonance imaging for diagnosis and follow-up of joint lesions in patients with haemophilia.Mutational Profiles of and in a Cohort of Haemophilia A and Haemophilia B Patients in the Multi-ethnic Malaysian Population
P2860
Q27027224-B3AF0C92-72F1-4950-9E55-0A69FF4F12F3Q30655343-46237A14-A4EF-4B20-81A7-9FE849428040Q34569046-02E6249F-C9B1-46A8-A20C-AF3AC2E90360Q36015787-76AA5792-508A-4EF2-8839-5334F7262117Q37015686-18B4A812-72FB-4526-B046-00961DB31C70Q37606315-4ACAD04A-FB0A-49F5-A858-44444BDD238FQ38101041-18422622-35DE-4308-B6E9-5B0D9A55B948Q38206863-5759E49F-1947-48A2-9255-2A496CF708C0Q38244389-3B8831BD-B1B0-47BC-A3DC-65851154209CQ38293116-AC424D71-A059-4EA1-8D85-E50BA3ABF64FQ38561882-A7AD58C5-192E-4065-86F8-E3FBCCE82E46Q38575475-7CF6D7BF-F054-42D7-B761-F67766659081Q38748723-FD61FB62-F84B-4B21-8653-85BEA9459F0BQ38833988-27DAC4BE-2978-4EA6-AE46-6DEEDF67644AQ41592459-1B0B39EA-EE0D-4EDC-963E-4D05E7A32226Q43527709-A5D7F3B8-1178-4AC4-AB4C-7E1F701C4CB4Q58775585-7BD01D7C-5DF0-4B69-8A62-EBEF626E5AD6
P2860
Increased prevalence of inhibitors in Hispanic patients with severe haemophilia A enrolled in the Universal Data Collection database.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Increased prevalence of inhibi ...... rsal Data Collection database.
@ast
Increased prevalence of inhibi ...... rsal Data Collection database.
@en
Increased prevalence of inhibi ...... rsal Data Collection database.
@nl
type
label
Increased prevalence of inhibi ...... rsal Data Collection database.
@ast
Increased prevalence of inhibi ...... rsal Data Collection database.
@en
Increased prevalence of inhibi ...... rsal Data Collection database.
@nl
prefLabel
Increased prevalence of inhibi ...... rsal Data Collection database.
@ast
Increased prevalence of inhibi ...... rsal Data Collection database.
@en
Increased prevalence of inhibi ...... rsal Data Collection database.
@nl
P2093
P2860
P1433
P1476
Increased prevalence of inhibi ...... rsal Data Collection database.
@en
P2093
Hemophilia Treatment Center Network (HTCN) Investigators
J Michael Soucie
S L Carpenter
P2860
P304
P356
10.1111/J.1365-2516.2011.02739.X
P577
2012-01-18T00:00:00Z